CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial
Nirali N. Shah(National Institutes of Health), Richard Aplenc(Children's Hospital of Philadelphia), Steven M. Devine(National Marrow Donor Program), Michael R. Verneris(NHS Blood and Transplant), Constance M. Yuan(National Cancer Institute), Brian Bowser(Frederick National Laboratory for Cancer Research), Terry J. Fry(University of Colorado Anschutz Medical Campus), Hati Kobusingye(National Marrow Donor Program), Sheryl Ruppel(Frederick National Laboratory for Cancer Research), Leslie S. Kean(Boston Children's Hospital), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Eric Ndifon(National Marrow Donor Program), Emily M. Hsieh(Children's Hospital of Los Angeles), Bonnie Yates(National Institutes of Health), Jason L. Yovandich(Bryan College), Erin Leckrone(National Marrow Donor Program), Dennis F. Michiel, Hemalatha G. Rangarajan(Nationwide Children's Hospital), Susanne H.C. Baumeister(Dana-Farber Cancer Institute), Sarah K. Tasian(Children's Hospital of Philadelphia), Ruta Brazauskas(Medical College of Wisconsin), M. Eric Kohler(University of Colorado Denver), Corinne Summers(Seattle Children's Hospital), Jessica A. Pollard(Maine Medical Center), Anthony Welch(The University of Sydney), Haneen Shalabi(Center for Cancer Research), Katherine Tarlock(Center for Cancer and Blood Disorders), Jeffery J. Auletta(Nationwide Children's Hospital), Larisa Broglie(Morgan Stanley Children's Hospital), Hao‐Wei Wang(Fu Jen Catholic University), George Mitra(Frederick National Laboratory for Cancer Research), Allison A Weiss(National Marrow Donor Program), John Roach(Frederick National Laboratory for Cancer Research), Rachelle Salomon(Cancer Institute (WIA)), Julie Blake(Frederick National Laboratory for Cancer Research), Michael A. Pulsipher(Primary Children's Hospital)
Cited by 62
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718